English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community

Biospace

Patient Daily | Feb 4, 2026

AstraZeneca announces $15 billion investment plan for cell therapies and manufacturing in China

Patient Daily | Feb 4, 2026

Sanofi sees dip in vaccine sales amid US policy changes but forecasts growth

Patient Daily | Feb 4, 2026

Roche targets third place in global obesity drug market after acquisitions

Patient Daily | Feb 4, 2026

Biotech investors focus on asset-centric deals amid shifting risks after JPM 2026

Patient Daily | Feb 4, 2026

Biotech IPO boom of 2021 faces reality check as sector recalibrates

Patient Daily | Feb 4, 2026

Moderna partners with Recordati on rare disease mRNA therapy worth up to $160 million

Patient Daily | Feb 4, 2026

Summit Therapeutics’ ivonescimab faces key FDA decision as potential Keytruda competitor

Patient Daily | Feb 4, 2026

White House delays launch of TrumpRx drug purchasing platform amid legal concerns

Trending

+ Pharmaceuticals
Patient Daily | Mar 16, 2026

Five therapies show progress in multiple myeloma treatment landscape

+ Regulatory
Patient Daily | Mar 9, 2026

Pharmacy owner Kiefer on PBMs: 'Independent pharmacies are being aggressively pushed out of business by the monopolistic practices of PBMs'

+ Pharmaceuticals
Patient Daily | Mar 9, 2026

Rep. Marshall on 340B expansion: 'If 340B is to continue growing, lawmakers should ensure it truly benefits the underserved'

+ Pharmaceuticals
Patient Daily | Mar 11, 2026

Alnylam partners with Tenaya Therapeutics on genetic heart disease research

  • « First
  • «
  • …
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily